Demet COŞKUN, Didem AKÇALI, Hülya ÇELEBİ

Hedef kontrollü infüzyon cihazı ile total intravenöz anestezi: propofol ve remifentanilin uyumlu beraberliği

Anestezide yaygın olarak kullanılan total intravenöz anestezi yöntemi, teknolojinin yıllar içinde gelişmesinden payını almış ve ilaçların farmakokinetik yazılımlarını içeren cihazlarla hastaya özel veriler hesaplanılarak uygulanan "Hedef Kontrollü Infiizyon" sistemi şeklinde geliştirilmiştir. Bu derlemede, uzun bir geçmişi olan. ancak ülkemizde son yıllarda kullanılmaya başlanan lıedef kontrollü infzüyon uygulamaları konusunda kaynaklar eşliğinde detaylı bilgi sunulmuştur.

Total intravenous anesthesia with target controlled infusion: the pleasant journey of propofol and remifentanil

Total intravenous anesthesia is a common technique for general anesthesia which has progressed by the help of technologic innovations to "Target Controlled Infusion" performed by infusion systems which include pharmacokinetic drug behavior software. In this review, detailed information in the view of literature about target controlled infusion which is old but available lately in our country is presented.

PDF

___

1. Target controlled infusion (TCI) in anaesthetic practice. Sweeden. Astra Zeneca Neuroscience, 2004; 1-64.
2. Absolom AR. Struys MRF. An overview of TCI & TIVA. Gent. Academia Press. 2"'ed. 2007; 1-108.
3. Cazalaâ JB, Lcvron JC. Servin F. Anesthetic agents using in TCI Sauveur. Frescnius Kabi. 2 "' ed. 2(X)9: 1-105.
4. Sneyd JR. Recent advances in intravenous anaesthesia, Br J Anaeslh 2004: 93:725-36.
5. Sneyd JR. Rigby-Jones AE. New drugs and technologies, intravenous anaesthesia is on the move (again). Br J Anaesih. 2010: 105:246-54.
6. Miller DR, Intravenous infusion anaesthesia and delivery devices. Can J Anaesth 1994: 41:639-52.
7. Pico U. An appliance to facilitate the administration of intravenous anaesthesia by continuous drip. Anesthesiology 1944: 5: 411-2.
X. Kay B. Roily G. I.C.I. 358ft8. a new intravenous induction agent. Acta Anaesthesiol Belg 1977; 28:303-16.
9. Minto C'F. The History and evolution of intravenous anaesthesia. In: TIVA-TC1 Book of Abstracts.. Geneva. Switzerland. Kenes International 2007: 2.
10. Schwilden H. A general method for calculation the dosage scheme in linear pharmacokinetics. Bur J Clin Pharmacol 1981; 20:379.
11. Schüttler J. Stoeckcl H, Schwilden II. Pharmacokinetic and pharmacodynamic modelling of propolol (Diprivan) in volunteers and surgical patients. Postgraduate Medical Journal 19X5: 61 (suppl 3): 53.
12. White M. Kenny GNC. Intravenous propofol anaesthesia used computerized infusion. Anaesthesia 1990: 45:204-9.
13. Kenny GN. White M. A portable computerised infusion system for propofol. Anaesthesia 1990 45:692-3.
14. Engbers F. Practical use of 'Diprifusor' systems Anaesthesia 1998: 53 (suppl ):28-34.
15. Karcı A. Anestezide Farmakolojinin Temel Prensipleri. Çeviri: Aydın D Iıı: Miller RD (ed). Miller Anestezi, Çeviri editörü: Aydın D, Güven Kitabevi. İzmir. 2010 : 67-1(14.
16. Ludbrook GL. Visco E. l-am AM. Propolol: relation between brain concentrations, electroencephalogram, middle cerebral artery blood How velocity, and cerebrai oxygen extraction during induction of anesthesia. Anesthesiology 2002; 97:1363-70. 17. Shal'er SL. Gregg KM. Algorithms to rapidly achieve and maintain stable drug concentrations at the site of drug effect with a computer -controlled infusion pump. J Pharmacokinet Biopharm 1992: 20:147-69.
18. Jacobs JR. Williams EA. Algorithm to control "effect compartment" drua concentrations in pharmacokinetic model-driven drug delivery. IEEE Trans Biomed Eng. 1993:40:993-9.
19. Schnider TW. Minto CF. Shaler SL. ve ark. The influence of age on propofol pharmacodynamics. Anesthesiology 1999; 90:1502- to.
20. Struys M. Versichclen L. Byttebier G, Mortier E. Moerman A. Roily G. Clinical usefulness of the bispectral index for titrating propofol target effect-site concentration. Anaesthesia 1998; 53:4-12.
21. Akçalı D, Çelebi H. İntravenöz İlaç İnfüzyon Sistemleri. Çeviri: Aydın D Iıı: Miller RD (ed). Miller Anestezi. Çeviri editörü: Aydın D. Güven Kitabevi. İzmir. 2010; 439-80.
22. Hughes MA. Glass PS. Jacobs JR. Context-sensitive half-time in multicompartment pharmacokinetic models lor intravenous anesthetic drugs. Anesthesiology 1992: 76:334-41.
23. Youngs EJ, Shafer St.. Pharmacokinetic parameters relevant to recovery from opioids. Anesthesiology. 1994:81:83.3-42. Erratum in: Anesthesiology 1995: 82:326.
24. Vuyk J. Mertcns MJ. Olofsen E. Bumi AG. Bovill JG. Propofol anesthesia and rational opioid selection: Determination of optimal EC50-EC95 propofol opioid concentrations that assure adequate anesthesia and a rapid return of consciousness. Anesthesiology 1997; 87:1549-62.
25. Scott LJ. Perry CM. Spotlight on rcmifcntanil for general anaesthesia 2005: 19:1069-74.
26. Yuill G. Simpson M. An introduction to total intravenous anaesthesia. Br J Anaesth 2002:2:24-6.
27. Glen JB. The devolopment of "Diprifusor*: a TCI system for propolol. Anaesthesia 1998; 53 (Suppl I): 13-21.
28. Guarracino F, Lapolla F. Cariello C, ve ark. Target controlled infusion: TCI. Minerva Anestesiol 2005: 71:335-7,
29. Mackenzie N. Grant IS. Propofol ('Diprivan') for continuous intravenous anaesthesia. A comparison with methohexitone. Postgrad Med J 1985 ;6I (Suppl 3V.70-5.
30. Roberts PL, Dixon J. Lewis GT. Tackley RM. Prys-Roberts C. Induction and maintenance of propofol anaesthesia. A manual infusion scheme. Anaesthesia 1988:43(Suppl): 14-7.
31 Karahıyık L.. Bozkırlı F. Çelebi H. Propofol-Alfcntanil ile total intravenöz anestezi: Genel anestezi ile karşılaştırmalı çalışma. Türk Anest ve Rean Cem Mecmuası 1994; 22:97-102.
32. Karabıyık L. Bozkırlı F. Çelebi H. Göksu N. Effect of nitrous oxide on middle ear pressure: A comparison between inhalational anaesthesia with nitrous oxide and TIVA. Eur J Anaesthesiol 1996; 13: 27-32.
33. Çelebi H. Bozkırlı F. Önder M. Riskli gerialrik olgularda propofol -ketamin ile total intravenöz anestezi (TİVA). Anestezi Dergisi 1995: 3:198-202.
34. Öcal E, Çelebi H. Bozkırlı F. Uzun süreli cerrahi girişimlerde propofol-alfentanil ile total intravenöz anestezi ve modifiye ııörolept anestezinin karşılaştırılması Anestezi Dergisi 1997:5:131-6.
35. Avaııoğlu G. Bozkırlı F. Çelebi H. Enfluran. halotan anestezisi ve TİVA (Propofol-alfentanil) sırasında vekuronyumun nöromüskUler iletiye etkisi. Anestezi Dergisi 1998: 6:118-23.
36. Donati F. Miller DR. Fiset P. Target-controlled infusion devices: are we missing much? Can J Anaesth 2011: 58:349-53.
37. Marslı B. White M, Morton N. Kenny GN. Pharmacokinetic model driven infusion of propofol in children. Br J Anaesth 1991: 67:41 -48.
3X. Schnider TW. Minto CF. Gambus PL. ve ark. The influence of method ol administration and covariates on the pharmacokinetics Of propofol in adult volunteers. Anesthesiology 1998; 8X:1170-82.
39. Gepls E. Camu F. Cockshott. Douglas EJ. Disposition of propofol administered as constant rate intravenous infusions in humans. Anesth Analg 1987: 6ft: 1256-63.
40. Coşkun D. Çelebi H, Karaca G, Karabıyık L. Remifentanil versus fentanyl compared in a target-controlled infusion of propofol anesthesia: quality of anesthesia and recovery profile. J Anesth. 2010:24:373-9.
41. Malili A. Coşkun D. İnan Karaca G, Akçalı DT. Karabıyık L. Karadenizli Y. Target-controlled infusion with remifntanil with propofol or dcsfluranc under bispectral index guidence: quality of anestehesia and recovery profile. JRMS 2011; lft:611-20.
42. Coşkun D. Glinaydiıı B. Taş A. İnan G, Çelebi H. Kaya K. A comparison of three different target-controlled remifentanil infusion rates during target-controlled pmpofbl infusion for oocyte retrieval. Clinics (Sao Paulo) 2011; 66:811-5.
43. Lysakowski C. Dumont L. Pellegrini M. Clergue F. Tassonyi E. Effects of fentanyl, alfentanil, remifentanil and sufentanil on loss of consciousness and bispectral index during propofol induction of anaesthesia. Br .1 Anaesth 2(H)I; 86:523-7.
44. Absalom AR, Lee M, Menon DK. ve ark. Predictivc performance of the Domino, llija/i and Clements models during low-dose target-controlled ketamine infusions in healthy volunteers. Br J Anaesth 2007:98:615-23.
45. Ward DS. Norton JR. Guivarc'h PII. Utman RS. Bailey PL. Pharmacodynamics and pharmacokinetics of propofol in a medium -chain triglyceride emulsion. Anesthesiology 2002; 97; 1401-8.
46. Bach AC. Babayan VK. Medium-chain trigliserides: an update. Am J Clin Nutr 1982; 36:950-62,
47. Yamakage M. Ivasaki S. Jeong S-W, Ishiyama S-l. Namiki A. Comparative study between propofol in a long-chain triglyceride during sedation with target-controlled infusion. Anaesth Intensive Care 2005: 33:351-5.
48. Roy R. Anesthesia's tribute to Clint Eastwood: propofol. the good, the bad. and the ugly. Curr Rev Postanesth Care Nurses 1991; 12:162-167.
49. Side Effect Committee Notice: Propofol (Diprivan) side effects. Ugerskrilt for Laeger 1990: 152:1176.
50. Parke TJ, Stevens JE. Rice ASC. ve ark. Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports. BMJ 1992: 305:613-6.
51. Çelebi H, Candan N. Günaydın B. Propofol infiizvon sendromu. Anestezi Dergisi 2007; 15:73-80.
52. Swinhoe CF, Peacock JE. Glen JB. Reiily CS. Evaluation of the predictive performance of a 'Diprifusor* TCI system. Anaesthesia 1998; 53 (Supp! 11:61-7.
53. Passot S. Servin E. Allary R. ve ark. Target-controlled versus manually-controlled infusion of propofol for direct laryngoscopy and bronchoscopy, Anesth Analg 2002; 94:1212-6.
54. Macquaire V. Cantraine F. Schmaltz D. Coussaert F.. Barvais L. Target-controlled infusion of propofol induction with or without plasma concentration constraint in high-risk adult patients undergoing cardiac surgery. Acta Anaesihesiol Scand 2002; 46:1010-6.
55. Slruys M. Versichelen L. Roily G. Influence of pre-anaesihetic medication on target propofol concentration using a 'Diprifusor' TCI system during ambulatory surgery. Anaesthesia 1998; 53 Suppl 1:68-71
56. Servin FS. Marchand-Maillet F. Desmonts JM. Influence of analgesic supplementation on the target propofol concentrations for anaesthesia with Diprifusor' TCI. Anaesthesia I998;53 Suppl 1:72-6.
57. Strays MM. Vereecke H. Moerman A, ve ark. Ability of the bispectral index, autoregressive modelling with exogenous input-derived auditory evoked potentials, and predicted propofol concentrations to measure patient responsiveness during anesthesia with propofol and remifentanil. Anesthesiology 2(X)3: 99:802-12.
58. Davidson JA. Macleod AD. Howie JC. White M. Kenny GN. Effective concentration 50 for propofol with and without 67V_____ nitrous oxide. Acta Anaesthesiol Scand 1993; 37:458-64.
59 Stuart PC. Stott SM. Millar A. Kenny GN. Russell D. Cp50 of propofol with and without nitrous oxide 67%. Br J Anaesth 2000; 84:638-9
60. Nicuwenhuijs DJ, Olofscn E. Romberg RR, ve ark. Response surface modeling of remifentaniI propofol interaction on cardiorespiratory control and bispcctral index. Anesthesiology 2003; 98:312-22.
61. Ouattara A. Boccara G. Lettiaire S. ve ark. Target-controlled infusion of propofol and remifentanil in cardiac anaesthesia: influence of age on predicted effect-site concentrations. Br J Anaesth 2003; 90:617-22.
62. Servin FS. Bougeois B. Gömeni R, Mentr^ F, Farinotti R. Desmonts JM. Pharmacokinetics of propofol administered by target -controlled infusion to alcoholic patients. Anesthesiology 2003: 99:576-85.
63. Bastin R. Barvais L. Mclot C. Vincent JL. Bcrre J. Preliminary results of prolonged target controlled infusion of sufentanil adjusted to an effort pain score after cardiac surgery. Acta Anaesthesiol Belg 2005; 56:31-6. 64. Ferreira DA. Nunes CS. Antunes L. Lobo F. Amorim P. Practical aspects of the use of target controlled inlustoii with remifentanil in neurosurgical patients: predicted cerebral concentrations at intubation, incision and extubation. Acta Anaesthesiol Belg 2006; 57:265-70.
65. Dressier 1. Fritzsche T, Cortina K. Pragst F. Spies C. Rundshagcn I. Psychomotor dysfunction after remifentanil/propolbl anaesthesia. Eur J Anaesihesiol 2007: 24:347-54.
66. Mertens MJ. Qlofsen E, Engbers 1 11. Burm AG. Bovill JG. Vuyk J. Propofol reduces perioperative remifentanil requirements in a synergistic manner: response surface modeling of perioperative rem i fentani I -propofol interactions. Anesthesiology 2003: 99:347-59.
67. Wietasch JK. Scholz M. Zinserling J, ve ark. The performance of a target-controlled infusion of propofol in combination with remifentanil: a clinical investigation with two propofol formulations. Anesth Analg 2006; 102:430-7.
68. Breslin DS. Mirakhur RK. Reid JE. Kyle A. Manual versus target-controlled infusion of propofol. Anaesthesia 2004; 59:1059-63.
69. Milne SE, Kenny GN. Schraag S. Propofol sparing effect of remifentanil using closed-loop anaesthesia. Br J Anaesth 2iX)3: 90:623-9.
70. Cafiero T. Cavallo LM, Frangiosa A, ve ark. Clinical comparison of remifentanil-sevofiurane vs. remifentanil-propofol for endoscopic endonasal transpheuoidal surgery. Eur J Anaesthesiol 2007: 24:441-6.
71. Albertin A. La Colla G. La Colla L. Bergonzt PC. Deni F. Motzo E. Effect site concentrations of remifentanil maintaining cardiovascular homeostasis in response to surgical stimuli during bispectral index guided propofol anestesia in seriously obese patients. Minerva Anestesiol 2006; 72:915-24.
72. Scheufier KM. Zentııer J. Total intravenous anesthesia lor intraoperative monitoring of the motor pathways: atı integral view combining clinical and experimental data. J Neurosurg 2002; 96:571 -9.
73. 1 loymork SC. Raeder J, Grimsmo B. Steen PA. Bispectral index, predicted and measured drug levels of target-controlled infusions of remifentanil and propofol during laparoscopic cholecystectomy and emergence. Acta Anaesthesiol Scand 2000: 44:1138-44.
74. White M. Schenkels MJ. Engbers FH. ve ark. Effect-site modelling of propofol using auditory evoked potentials. Br J Anaesth 1W9; 82:333-9.
75. Triem JG. Rölım KD. Boldl J. Piper SN. Comparison of a propofol -based anesthesia regimen using optimated-target-controlled-infusion (OTCI) and manually-controlled infusion (MCI) technique. Anasthesiol Intensivmed Notfallmed Schmerzther 2006; 41:150-5.
76. Russell D. Wilkes MP. Hunter SC. ve ark. Manual compared with target-control led infusion of propofol. Br J Anaesth 1995; 75:562-6.
77. Lehmann A. Boldt J, Thaler E, Piper S. Weissc U. Bispectral index in patients with target-controlled or manually-coııtroiled infusion of propofol. Anesth Analg 2002: 95:639-44. '
78. Leslie K. Clavisi O, Hargrove J. Target-controlled infusion versus manually-controlled infusion of propofol for general anaesthesia or sedation in adults. Cochrane Database Syst Rev 2008: 16 (3): CD006059.
79. Servin F, Farinotti R. Haberer JP, Desmonts JM. Propofol infusion for maintenance of anesthesia in morbidly obese patients receiving nitrous oxide. A clinical and pharmacokinetic study. Anesthesiology 1993; 78:657-65.
80. Albertin A. Poli D. La Colla L, ve ark. Preditive performance of "Scrvin's formula' during BIS-guided propofol-remifentanil target -controlled infusion in morbidly obese patients. Br J Anaesth 2007: 98:66-75.
81. La Colla L. Albertin A. La Colla G. ve ark. No adjustment vs. adjustment formula as input weight for propofol target-controlled infusion in morbidly obese patients. Eur J Anaesthesiol 2009; 26:362-9.
82. Absalom A. Kenny GN. Current and future applications of target-controlled infusions. Drugs Today (Bare) 1999: 35:823-34.
83. Kenny GN. Mantzaridis H. Closed-loop control ol propofol anaesthesia. Br J Anaest. 1999; 83:223-8.
84. Strays M. De Smel T. Versichelen LF. Van De Velde S. Van den Broecke R. Mortier EP. Comparison ol closed-loop controlled administration of propofol using Bispcctral Index as the controlled variable versus "Standart Practice" controlled administration. Anesthesiology 2001: l>5:6-17.
85. Morley A. Derrick J. Mainland P, Lee KB, Shon TG. Closed loop control of anaesthesia: an assessment of the bispectral index as the target of control. Anaesthesia 2(XX): 55:953-9.
86. Souron V. Deluunay L, Bonner F. Sedation with target-controlled propofol infusion during shoulder surgery under inierscalene brachial plexus block in the sitting position: report of a series of 140 patients. Eur .1 Anaesthesiol 2005; 22:853-7.
87. Servin FS. Remifentanil: an update. Curr Opin Anaesthesiol 2003; 16:367-72.
88. James MK. Feldman PL. Schuster SV. Bilotta JM. Brackeen MF, Leighton HJ. Opioid receptor activity of G1 87084B. a novel ultra -short acting analgesic, in isolated tissues. J Pharmacol Exp Ther 1991; 259:712-8."
89. Egaıı TD. Pharmacokinetics and pharmacodynamics of remifentanil: an update in the year 2000. Curr Opin Anaesth 2000; 13:449-55.
90. Lentschener C. Ghimouz A. Bonnichon P, Pepion C, Gomola A. Ozier Y. Remifentanil-propofol vs. sufentanil-propofol: optimal combinations in clinical anesthesia. Acta Anaesthesiol Stand 2003; 47:84-9.
91. Guignard B. Bossard AE. Coste C. ve ark. Acute opioid tolerance: intraoperative remifentanil increases postoperative pain and morphine reguirement. Anesthesiology 2000: 93:409-17.
92. Crankshaw DP, Chan C. Leslie K. Bjorksten AR. Remifentanil concentration during target-controlled infusion of propofol. Anaesth Intens Care 2002; 30:578-83.
93. Bauillon T. Brulm J. Radu-Radulescu L. Bertaccini E. Park S. Shaler S. Non-steady-state analysis of the pharmacokinetic interaction between propofol and remifentanil. Anesthesiology 2002; 97:1350-62.
94. Kan RE. Huges SC. Rosen MA. Kessin C. Preston PG. Lobo EP. Intravenous remifentanil: placental transfer, maternal and neonatal effects. Anesthesiology 1998; 88:1467-74.
95. Scott JC. Stanski DR. Decreased fentanyl and alfentani) dose requirements with age. A simultaneous pharmacokinetic and pharmacodynamic evaluation. J Pharmacol Exp Ther 1987; 240:159-66."
96. Shafer SL, Varvel JR. Pharmacokinetic, pharmacodynamics, and rational opioid selection. Anesthesiology 1991; 74:53-63.
97. Gepts E, Shafer SL. Caınu F. ve ark. Linearity of pharmacokinetics and model estimation of sufentanil. Anesthesiology 1995: 83:1194-204.
98. Minto CF. Schnider TW, Egan TD. ve ark. Infuence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. 1. Model development. Anesthesiology 1997; 86:10-23.
99. Minto CF. Schnider TW. Shafer SL. Pharmacokinetics and pharmacodynamics of remifentanil. II. Model application. Anesthesiology 1997; 86:24-3.
100.De Castro V, Godet G. Mencia G. Raux M. Coriat P. Target -controlled infusion lor remifentanil in vascular patients improves hemodynamics and decreases remifentanil requirement. Anesth Analg 2003; 96:33-8.
101.Röpcke H. Könen-Bergmann M. Cuhls M, Bouillon T, Hocfı A. Propofol and remifentanil pharmacodynamic interaction during orthopedic surgical procedures as measured bv effects on bispectral index. J Clin Anesth 2001:13:198-207.
l02.Schraag S. Kenny GN. Mohl U. Georgieff M. Patient-maintained remifentanil target-controlled infusion for the transition to early postoperative analgesia. Br J Anaesth 1998; 81:365-8.
103.Drover DR. Lemmens HJ. Population pharmacodynamics and pharmacokinetics of remifentanil as a supplement lo nitrous oxide anesthesia for elective abdominal surgery. Anesthesiology 1998: 89:869-77.
104.Hans P. Bonhomme V, Born JD, Maertens de Noordhoudt A. Brichant JF. Dewandre PY. Target-controlled infusion of propofol and remifentanil combined with bispectral index monitoring for awake craniotomy. Anaesthesia 2000; 55:255-9.
105.Egan TD, Huizinga B. Gupta SK. ve ark. Remifentanil pharmacokinetics in obese versus lean patients. Anesthesiology 1998 ;89:562-73.
l06.Slepchenko G. Simon N. Goubaux B. Levron JC. Le Moing JP. Raucoules-Aime M. Performance of target-controlled sufentanil infusion in obese patients. Anesthesiology 2003; 98:65-73. 107.Edwards J A. Kinsella J. Shaw A. Evans S. Anderson KJ. Sedation for oocyte retrieval using target controlled infusion of propofol and incremental alfentani) delivered by non-anaesthetists. Anaesthesia 2010:65:453-61.
108.Anderson BJ, Hodkinson B. Are there still limitations for the use of target-controlled infusion in children? Curr Opin Anaesthesiol 2010:23:356-62.
109. Anderson BJ. Pediatric models for adult target-controlled infusion pumps, Paediatr Anaesth 2010; 20:223-32.
I lO.Kataria BK. Ved S A. Nicodemus HF, ve ark. The pharmacokinetics of propofol in children using three different data analysis approaches. Anesthesiology 1994; 80:104-22.
111. Absolom A. Amotike D. Lai A, White M. Kenny GN. Accuracy of the 'Paedfuser' in children undegoing cardiac surgery or catheterization. Br J Anaesth 2003; 91 ;507-l 3.
112.Minardi C. Astuto M. Taranto V. Gullo C. Gullo A. Combination of propofol and remifentanil target-controlled infusion lor laryngeal mask airway insertion in children some remarks, Minerva Anestesiol 2011:77:1-2.
113.Jeleazcov C. Ihmsen II. Schmidt J, ve ark. Pharmacodynamic modelling of the bispectral index response to propofol-based anaesthesia during general surgery in children. Br J Anaesth 2008; 100:509-16.
114.1wakiri H. Nishihara N, Nagata O. Matsukawa T, Ozaki M. Sessler Dl. Individual effect-site concentrations of propofol are similar at loss of consciousness and at awakening. Anesth Analg 2005: 100:107-10.
115.McCormack J. Mehta D, Pciris K, ve ark. The effect of a target controlled infusion of propofol on predictability of recovery from anesthesia in children. Paediatr Anaesth 2010; 20:56-62.
116.Viviand X. Bourgoin A. Target-controlled infusion in children. Adv F.xp Med Biol 2003: 523:161-70.
117. Viviand X, Berdugo L, De La Noe CA, Uindo A, Martin C. Target concentration of propofol required to insert the laryngeal mask airway in children. Paediatr Anaesth 2003:13:217-22.'
118.Park HJ. Lee JR. Kim CS. Kim SD. Kim HS. Remifentanil halves the EC50 of propofol for successful insertion of the laryngeal mask airway and laryngeal tube in pediatric patients. Anesth Analg 2007: 105:57-61.
119.Kim HS. Park HJ. Kim CS. Lee JR. Combination of propofol and remifentanil target-controlled infusion for laryngeal mask airway insertion in children. Minerva Anestesiol 2011: 77:687-92.
120.Auricchio F, Baldinelli F. Evaluation of Constant Plasma Equilibrium - Effect Site (Keo) and Propofol: Comparison of BIS - AEP in Children In: T1VA-TC1 Book of Abstracts.. Geneva. Switzerland. Kenes International. 2007; 50.
121 Liu N. Bourgeois E, Chazot T. Murat I. Fischler M. Closed-loop administration of propofol and remifentanil guided by the Bispectral Index in patient requiring an emergency lung volume reduction. Paediatr Anaesth 2007: 17:909-10. "
122. Bourgoin A. Albanese J, L^one M, Sampol-Manos E, Viviand X. Marlin C. Effects of sufentanil or ketamine administered in target-controlled infusion on the cerebral hemodynamics of severely brain-injured patients. Crit Care Med 2(X.)5: 33:1109-13.
123.Di Marco P. Pelorosso S. Ghezzi 1. ve ark. Ketamine: A new old drug. In: TIVA-TCI Book of Abstracts.. Geneva. Switzerland. Kenes International. 2007; 6-7.
124.Domino EF. Zsigmond EK, Domino LE, Domino KE, Kothary SP. Domino SE. Plasma levels of ketamine and two of its metabolites in surgical patients using a gas chromatographic mass fragmentographic assay. Anesth Analg 1982: 61:87-92.
125.Hijazi Y. Bodonian C, Bolon M. Salord F. Boulieu R. Pharmacokinetics and haemodynamics of ketamine in intensive care patients with brain or spinal cord injury. Br J Anaesth. 2003; 90:155-60.
126.Baik HJ. Kim JH. lx-e CM. Laryngeal mask insertion during target-controlled infusion of propofol. J Clin Anesth 2001: 13: 175-81.
127.Gray C. Swinhoe CF. Myint Y. Mason D. Target Controlled infusion of kctamin as analgesia for TIVA with propofol. Can J Anesth 1999:46:957-61.